Medical Organic Marijuana in Sydney, Australia | Investment management company

Medical Organic Marijuana

Locality: Sydney, Australia

Address: 50 Clarence St, 2000 Sydney, NSW, Australia

Website: https://www.medicinalorganiccannabis.org

Likes: 857

Add/Update information

Reviews

Tags

• Medical and health
• Alternative & holistic health service
• Investment management company
• Investing service
• Medical cannabis dispensary

20.01.2022 Leading medical cannabis researcher, Israel, will be host to the world’s first government supported cannabis technology incubator.

19.01.2022 More than 2,000 people placed orders within the first hour that cannabis-infused edibles and vape products became available for sale on the Ontario Cannabis Store’s website, a spokesperson told BNN Bloomberg

19.01.2022 Join us for a live Q & A session with Alessandro Sorbello discussing the MOCA's activities and investment opportunities via the upcoming equity crowd funding campaign.

16.01.2022 We’ve created an innovative way to lower the product cost to patients by up to 30% of current retail prices. We have also been working directly with cultivators to positively influence and improve the methodology of organic farming practices. PledgeMe

15.01.2022 Modified form of medicinal cannabis can kill or inhibit cancer cells without impacting normal cells, revealing its potential as a treatment rather than simply a relief medication, according to laboratory tests conducted at the University of Newcastle and Hunter Medical Research Institute. Cancer researcher Dr Matt Dun and his team ran comparisons between other cannabis strains containing THC and those with low levels of THC but with high levels of CBD. For both leukaemia and ...paediatric brainstem glioma, the cannabis with high CBD levels was more effective at killing cancer cells than THC varieties. There are trials around the world testing cannabis formulations containing THC as a cancer treatment, but if you’re on that therapy your quality of life is impacted, Dr Dun says. You can’t drive, for example, and clinicians are justifiably reluctant to prescribe a child something that could cause hallucinations or other side-effects. The CBD variety looks to have greater efficacy, low toxicity and fewer side-effects, which potentially makes it an ideal complementary therapy to combine with other anti-cancer compounds. The next phase for the study includes investigating what makes cancer cells sensitive and normal cells not, whether it is clinically relevant, and whether a variety of cancers respond.

15.01.2022 Cannabis investing

14.01.2022 Two years ago, Canadian cannabis companies were racing to scoop up international assets, from swaths of fertile land in southern Africa to cultivation licences in Jamaica and everything in between.

13.01.2022 https://mjbizdaily.com/expected-delay-in-vote-on-who-canna/

12.01.2022 #Condividiamo #Informaperlariforma #Caliweed #Suoreverdi #Hemp

11.01.2022 Emerald Clinics, a company that specialises in cannabinoid treatments, has launched a $6-8 million IPO ahead of a launch on the ASX next month. The company has four clinics in Sydney, Melbourne, Perth and the Northern Rivers region of NSW, providing safe access to cannabinoid medicines for qualified patients in collaboration with referring doctors.

11.01.2022 A growing number of parents of autistic children are coming out in support of medical cannabis, saying that their children show miraculous results for a condition that often seems hopeless.

10.01.2022 The UK’s leading oncologist has joined Block Commodities Ltd to unlock opportunities in the CBD wellness and medical cannabis market. Block Commodities, a commodity-focussed trading company aiming to maximise value in African agriculture through the deployment of blockchain technologies, recently announced the appointments of Professor Justin Stebbing and Professor Andrew Garner to its Scientific Advisory Team (SAT) earlier this week to play a central role in helping the Board to identify and unlock suitable investment opportunities in the CBD wellness and medical cannabis market.

07.01.2022 A long-standing member of the UK Government Regulatory Agency Medicines Commission and King’s College, London professor has been appointed as chairman of the European Medicinal Cannabis Association.

05.01.2022 How do cannabis patches work for Fibromyalgia, read this https://cannabis.net//new-cannabis-patch-for-fibromyalgia-

04.01.2022 MOCA - Medicinal Organic Cannabis Australia (MOCA) has officially launched its Australian equity crowdfunding campaign with PledgeMe. Do you know an Australian citizen or resident who would want to co-own this company? Spread the word! Or are you an interested investor? Equity crowdfunding makes investment affordable and YOU can join the MOCA crowd if you like! Learn more about the campaign (links in Comments) Please make sure to read the risk warning statement and offer docu...ment before investing. https://www.youtube.com/watch?v=3QGKQnCgpXw

04.01.2022 A popular cannabis-derived epilepsy treatment is increasing sales for a London company making pharmaceutical treatments from marijuana. London-based GW Pharmaceuticals told investors Monday that it rang up $108 million in sales last quarter and $309 million for calendar 2019.